Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Virginia, Reddy"'
Autor:
Virginia Reddy, Stanley B. Cohen
Publikováno v:
Current Opinion in Rheumatology. 33:300-306
Purpose of review To review recently published articles on use of Janus Kinase inhibitors (Jaki) in the clinic for rheumatoid arthritis (RA). Recent findings Several Jaki have been approved for RA patients failing csDMARDS. Over the last 2 years, EUL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7249a94b0453f76024a93274e2ebde8
https://doi.org/10.1097/bor.0000000000000792
https://doi.org/10.1097/bor.0000000000000792
Autor:
Virginia, Reddy, Stanley, Cohen
Publikováno v:
Current opinion in rheumatology. 33(3)
To review recently published articles on use of Janus Kinase inhibitors (Jaki) in the clinic for rheumatoid arthritis (RA).Several Jaki have been approved for RA patients failing csDMARDS. Over the last 2 years, EULAR and ACR have published updated r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b241657fc39ec64fc869c7779c322411
https://pubmed.ncbi.nlm.nih.gov/33767091
https://pubmed.ncbi.nlm.nih.gov/33767091
Autor:
Virginia Reddy, Stanley B. Cohen
Publikováno v:
Current rheumatology reports. 22(9)
Three Janus kinase (JAK) inhibitors are approved for rheumatoid arthritis (RA) with a fourth awaiting approval. Multiple clinical trial results with these molecules have recently been reported. These were the first small molecule oral targeted synthe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7652d00977d339b67a45832a73a4824
https://pubmed.ncbi.nlm.nih.gov/32700001
https://pubmed.ncbi.nlm.nih.gov/32700001
Autor:
Joanne Valeriano-Marcet, Amy Joseph, Ted R. Mikuls, J. Rodrigues, Thomas Olenginski, Cynthia Weaver, Salahuddin Kazi, Pamela E. Prete, Ciaran S. Phibbs, James R. O'Dell, Peter D. Kent, Keri Hannagan, Samardeep Gupta, Jay E. Persselin, Keith K. Colburn, Erika Holmberg, Virginia Reddy, David I. Daikh, Joseph Fanciullo, Liam Martin, Gail S. Kerr, Aslam H. Anis, Lynne Peterson, Sarah Leatherman, Karen S. Kolba, Hani El-Gabalawy, Raymond Hausch, Andrew Chow, Andreas M. Reimold, Vivian P. Bykerk, William T. Ayoub, Huiying Sun, Gilles Boire, John M. Davis, David Pugliese, H. Ralph Schumacher, Edward C. Keystone, Mary Brophy, Mahfooz Peshimam, C. Kent Kwoh, Jennifer R. Elliott, J. Carter Thorne, Maren L. Mahowald, Nick Bansback
Publikováno v:
Annals of internal medicine. 167(1)
The RACAT (Rheumatoid Arthritis Comparison of Active Therapies) trial found triple therapy to be noninferior to etanercept-methotrexate in patients with active rheumatoid arthritis (RA).To determine the cost-effectiveness of etanercept-methotrexate v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d68e3161a911718991c2494b41cae48e
https://pubmed.ncbi.nlm.nih.gov/28554192
https://pubmed.ncbi.nlm.nih.gov/28554192
Autor:
Prabha, Ranganathan, Robert, Culverhouse, Sharon, Marsh, Ami, Mody, Tiffany J, Scott-Horton, Richard, Brasington, Amy, Joseph, Virginia, Reddy, Seth, Eisen, Howard L, McLeod
Publikováno v:
The Journal of rheumatology. 35(4)
Research has examined the association of folate-dependent gene polymorphisms with methotrexate (MTX) toxicity in racially homogenous patients with rheumatoid arthritis (RA). We examined the influence of MTX transporter gene polymorphisms on MTX toxic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b60acbe886a7c3e94f83ca25699e5b9f
https://pubmed.ncbi.nlm.nih.gov/18398948
https://pubmed.ncbi.nlm.nih.gov/18398948